Advertisement

ACAAI responds to proposed FL ban on vaccine mandates

| September 4, 2025

ACAAI responds to proposed FL ban on vaccine mandates

The American College of Allergy, Asthma and Immunology (ACAAI)—a professional organization representing more than 6,000 allergists/immunologists, allied health professionals, and the millions of patients they serve—notes with concern Florida’s recent decision to discontinue school vaccine mandates for children.

Vaccines have long been a cornerstone of public health. They are rigorously studied and monitored for safety and have proven effective in reducing the spread of serious, and often highly contagious, viral and bacterial infections. For decades, school vaccine requirements across the country have helped maintain high levels of community immunity and protect vulnerable populations.

As board-certified experts in immunologic conditions—including asthma, eczema, and immune deficiencies—our members care for many patients who are especially susceptible to infections. Some of these individuals cannot receive vaccines due to underlying medical conditions and must rely on herd immunity for protection. Even small declines in community vaccination rates can result in serious consequences for these at-risk individuals.

This year, the U.S. experienced its largest measles outbreak in 25 years, with more than 1,400 reported cases and several deaths—primarily among unvaccinated individuals. Removing long-standing vaccination requirements increases the risk of similar outbreaks, not only within Florida but beyond, given the ease of domestic travel and the transmissibility of certain diseases.

While we recognize the complex legal, ethical, and societal dimensions surrounding vaccine policy, the ACAAI respectfully urges policymakers to weigh the unintended public health implications of this change. Decisions impacting vaccine access and coverage affect not only individual families but entire communities, including those least able to protect themselves, especially children, the elderly, and those who are immunocompromised.

Advertisement